FIELD: medicine.
SUBSTANCE: to obtain a biodegradable implant, aqueous solutions of glycosaminoglycans, lactic acid and polyvinylpyrrolidone polymers and/or copolymers are extruded with formation of seeds - "dry" ellipsoids of rotation, dried and cross-linked by gamma radiation. Seeds are transferred to an aqueous solution of the said polymers and/or copolymers with a dissolved drug substance, kept for 30-120 minutes, extruded and crosslinked by gamma radiation. Extrusion is repeated with alternation of solutions containing and not containing a drug substance, forming a multilayer implant with a maximum dimension of 3.0-5.0 mm along the longitudinal axis, 0.1-0.3 mm along the transverse axis.
EFFECT: achievement and maintenance of the required drug substance concentration in the vitreous cavity.
2 cl
Title | Year | Author | Number |
---|---|---|---|
BIODEGRADABLE MULTILAYER IMPLANT FOR ADMINISTERING DRUG SUBSTANCES INTO VITREAL CAVITY OF EYE | 2014 |
|
RU2557925C1 |
METHOD FOR DRUG DELIVERY TO POSTERIOR EYEBALL SEGMENT STRUCTURES | 2015 |
|
RU2583599C1 |
INTRAOCULAR IMPLANTS CONTAINING PROSTAMIDES | 2014 |
|
RU2666603C2 |
EYE IMPLANTAT PREPARED BY DOUBLE EXTRUSION METHOD | 2005 |
|
RU2389479C2 |
BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR LONG-TERM RELEASE OF PROTEIN | 2013 |
|
RU2676102C2 |
INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
METHODS FOR TREATING PATHOLOGY OF EYE BY MEANS OF IMPLANT WITH DURABLE DELIVERY OF DRUG SUBJECTS | 2014 |
|
RU2690841C1 |
OPHTHALMIC DROPS | 2002 |
|
RU2216331C1 |
DEXAMETHASONE CONJUGATE WITH SYNTHETIC STATISTICAL POLYPEPTIDE | 2020 |
|
RU2792146C2 |
METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
Authors
Dates
2017-05-23—Published
2015-12-17—Filed